Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.102
-0.008 (-0.72%)
At close: Mar 27, 2026, 4:00 PM EDT
1.110
+0.008 (0.73%)
After-hours: Mar 27, 2026, 4:00 PM EDT

Boundless Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
17.8726.5923.7110.9534.29
Short-Term Investments
89.71125.5397.0555.7738.74
Cash & Short-Term Investments
107.58152.11120.7566.7273.03
Cash Growth
-29.28%25.97%80.99%-8.65%-
Other Current Assets
2.032.283.451.321.54
Total Current Assets
109.61154.39124.268.0474.57
Net Property, Plant & Equipment
46.8851.364.587.733.1
Long-Term Investments
----34.99
Other Long-Term Assets
0.570.661.121.071.07
Total Assets
157.06206.41129.8976.83113.72
Accounts Payable
6.735.354.272.841.98
Accrued Expenses
2.642.782.92.461.31
Current Portion of Leases
3.17-2.22.340.38
Other Current Liabilities
---0.090.21
Total Current Liabilities
12.548.149.367.733.87
Long-Term Leases
45.8747.63-2.85-
Other Long-Term Liabilities
---0.010.1
Total Long-Term Liabilities
45.8747.63-2.850.1
Total Liabilities
58.4155.779.3610.583.96
Common Stock
00--0
Additional Paid-in Capital
358.26351.998.995.382.76
Accumulated Other Comprehensive Income
0.060.120.04-0.4-0.18
Retained Earnings
-259.67-201.47-136.11-86.68-40.77
Total Common Shareholders' Equity
98.65150.64-127.08-81.7-38.19
Minority Interest
--247.62147.95147.95
Shareholders' Equity
98.65150.64120.5466.25109.76
Total Liabilities & Equity
157.06206.41129.8976.83113.72
Total Debt
49.0447.632.25.180.38
Net Cash (Debt)
58.55104.48118.5661.5372.66
Net Cash Growth
-43.96%-11.87%92.67%-15.31%-
Net Cash Per Share
2.626.1597.5056.0484.43
Book Value
98.65150.64-127.08-81.7-38.19
Book Value Per Share
4.418.87-104.51-74.40-44.38
Tangible Book Value
98.65150.64-127.08-81.7-38.19
Tangible Book Value Per Share
4.418.87-104.51-74.40-44.38
Updated Mar 9, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q